002262 恩华药业
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额621,8371,008,300861,023701,1181,248,349
投资活动产生之现金流量净额(949,082)(293,391)(688,902)(392,522)(911,950)
筹资活动产生之现金流量净额(309,789)(210,174)(240,779)(127,434)(305,071)
汇率变动对现金及现金等价物的影响177415908(1,145)(380)
现金及现金等价物净增加/(减少)(636,857)505,150(67,750)180,01730,947
期初现金及现金等价物余额2,009,6131,504,4631,572,2121,392,1951,361,248
期末现金及现金等价物余额1,372,7562,009,6131,504,4631,572,2121,392,195